Summary
Medtronic Plc (Medtronic), formerly Medtronic, Inc., is a medical technology company. It develops, manufactures and markets a wide range of medical devices, therapies and services for the treatment of conditions such as heart disease, spinal conditions, neurological disorders, vascular disease, orthopedic disorders and diabetes. The company sells its products through direct sales force in the US and a combination of direct sales representatives and independent distributors outside the US. The company serves hospitals, clinics, third-party health care providers, distributors, and institutions including governmental health care programs and group purchasing organizations (GPOs) in Asia Pacific, Europe, the Americas, the Middle East and Africa. Medtronic is headquartered in Dublin, Ireland.
Medtronic Plc (MDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Medtronic Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Medtronic Plc, Medical Devices Deals, 2011 to YTD 2017 12
Medtronic Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
Medtronic Plc, Pharmaceuticals & Healthcare, Deal Details 17
Asset Purchase 17
Given Imaging Acquires SmartPill GI Monitoring Assets From SmartPill For US$6 Million 17
Venture Financing 18
MD Start Secures USD11.5 Million in Venture Funding 18
Semma Therapeutics Raises USD44 Million in Series A Financing 19
AcuFocus Raises USD21 Million in Venture Financing 20
Sapheon Raises US$20 Million In Series B Financing 22
Intersect ENT Raises US$30 Million In Series D Financing 23
Visualase Secures USD5.2 Million in Series B Funding 25
Spinal Modulation Secures US$30 Million In Series D Financing 26
Partnerships 28
Sanofi Enters into Co-Development Agreement with Medtronic 28
Mallinckrodt Pharma And Medtronic Enter Into Clinical Agreement For Intrathecal Therapeutics 29
Arca Biopharma Enters Into Co-Development Agreement With Medtronic For Gencaro 30
Medtronic Plans To Enter Into Agreement With Pharma Companies For Alzheimer's 31
Aircraft Medical Enters Into Distribution Agreement With Covidien For McGRATH MAC Video Laryngoscope 32
Eli Lilly Enters Into Collaboration With Medtronic 34
Nile Therapeutics Enters Into An Agreement With Medtronic 35
Licensing Agreements 36
Acorda Therapeutics Enters Into Licensing Agreement With Medtronic For AC105 36
Equity Offering 38
GI Dynamics Completes Private Placement Of CHESS Depository Interests For US$21 Million 38
Tengion Completes Private Placement Of Shares For US$31.4 Million 40
Debt Offering 42
Medtronic Raises USD4 Billion in Private Placement of 4.625% Notes Due 2045 42
Medtronic Raises USD500 Million in Private Placement of Notes Due 2020 43
Medtronic Raises USD2.5 Billion in Private Placement of 3.15% Notes Due 2022 44
Medtronic Raises USD4 Billion in Private Placement of 3.5% Notes Due 2025 45
Medtronic Raises USD2.5 Billion in Private Placement of 4.375% Notes Due 2035 46
Medtronic Raises USD1 Billion in Private Placement of Notes Due 2018 47
Medtronic Raises USD2.5 Billion in Private Placement of 2.5% Notes Due 2020 48
Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 49
Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 51
Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 53
Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 55
Covidien Completes Public Offering Of Notes Due 2023 For US$750 Million 57
Covidien Completes Private Placement Of Notes Due 2018 For US$300 Million 59
Covidien Completes Private Placement Of Notes Due 2023 For US$600 Million 60
Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 61
Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 63
Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 65
Covidien Completes Public Offering Of Senior Notes Due 2022 For US$650 Million 67
Covidien Completes Public Offering Of Senior Notes Due 2015 For US$600 Million 68
Medtronic Completes Public Offering Of 3.125% Senior Notes Due 2022 For US$675 Million 69
Medtronic Completes Public Offering Of 4.5% Senior Notes Due 2042 For US$400 Million 71
Medtronic Completes Public Offering Of Senior Notes Due 2021 For US$500 Million 73
Medtronic Completes Public Offering Of Senior Notes Due 2016 For US$500 Million 74
Asset Transactions 75
Spectranetics Acquires Stellarex from Covidien for USD30 Million 75
Capricor Therapeutics Acquires Intellectual Property Rights to Natriuretic Peptides from Medtronic 76
Covidien Plans to Divest Vascular Therapies Business 77
Acquisition 78
Medtronic Acquires Diabeter 78
Medtronic Acquires Covidien for USD49.9 Billion 79
Medtronic May Acquire Smith & Nephew 81
Medtronic Plc - Key Competitors 82
Medtronic Plc - Key Employees 83
Medtronic Plc - Locations And Subsidiaries 85
Head Office 85
Other Locations & Subsidiaries 85
Recent Developments 95
Strategy And Business Planning 95
Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 95
Financial Announcements 96
May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 96
Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 99
Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 102
Aug 25, 2016: Medtronic Reports First Quarter Financial Results 105
May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 108
Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 111
Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 113
Corporate Communications 114
May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 114
Legal and Regulatory 115
Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 115
Government and Public Interest 116
Sep 20, 2016: National Patient Safety Foundation's Lucian Leape Institute Awarded $1 Million Grant from Medtronic 116
Sep 13, 2016: Medtronic Foundation Issues $250,000 in Health Access Grants to Support Local Diabetes Services in Northridge, California 117
Other Significant Developments 118
Nov 24, 2016: S-CAPE and Medtronic Unveil State-of-the-art Operating Rooms in Spain 118
Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 119
Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 120
Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 121
Appendix 122
Methodology 122
About GlobalData 122
Contact Us 122
Disclaimer 122
List of Tables
Medtronic Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Medtronic Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Medtronic Plc, Deals By Therapy Area, 2011 to YTD 2017 10
Medtronic Plc, Medical Devices Deals, 2011 to YTD 2017 12
Medtronic Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
Given Imaging Acquires SmartPill GI Monitoring Assets From SmartPill For US$6 Million 17
MD Start Secures USD11.5 Million in Venture Funding 18
Semma Therapeutics Raises USD44 Million in Series A Financing 19
AcuFocus Raises USD21 Million in Venture Financing 20
Sapheon Raises US$20 Million In Series B Financing 22
Intersect ENT Raises US$30 Million In Series D Financing 23
Visualase Secures USD5.2 Million in Series B Funding 25
Spinal Modulation Secures US$30 Million In Series D Financing 26
Sanofi Enters into Co-Development Agreement with Medtronic 28
Mallinckrodt Pharma And Medtronic Enter Into Clinical Agreement For Intrathecal Therapeutics 29
Arca Biopharma Enters Into Co-Development Agreement With Medtronic For Gencaro 30
Medtronic Plans To Enter Into Agreement With Pharma Companies For Alzheimer's 31
Aircraft Medical Enters Into Distribution Agreement With Covidien For McGRATH MAC Video Laryngoscope 32
Eli Lilly Enters Into Collaboration With Medtronic 34
Nile Therapeutics Enters Into An Agreement With Medtronic 35
Acorda Therapeutics Enters Into Licensing Agreement With Medtronic For AC105 36
GI Dynamics Completes Private Placement Of CHESS Depository Interests For US$21 Million 38
Tengion Completes Private Placement Of Shares For US$31.4 Million 40
Medtronic Raises USD4 Billion in Private Placement of 4.625% Notes Due 2045 42
Medtronic Raises USD500 Million in Private Placement of Notes Due 2020 43
Medtronic Raises USD2.5 Billion in Private Placement of 3.15% Notes Due 2022 44
Medtronic Raises USD4 Billion in Private Placement of 3.5% Notes Due 2025 45
Medtronic Raises USD2.5 Billion in Private Placement of 4.375% Notes Due 2035 46
Medtronic Raises USD1 Billion in Private Placement of Notes Due 2018 47
Medtronic Raises USD2.5 Billion in Private Placement of 2.5% Notes Due 2020 48
Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 49
Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 51
Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 53
Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 55
Covidien Completes Public Offering Of Notes Due 2023 For US$750 Million 57
Covidien Completes Private Placement Of Notes Due 2018 For US$300 Million 59
Covidien Completes Private Placement Of Notes Due 2023 For US$600 Million 60
Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 61
Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 63
Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 65
Covidien Completes Public Offering Of Senior Notes Due 2022 For US$650 Million 67
Covidien Completes Public Offering Of Senior Notes Due 2015 For US$600 Million 68
Medtronic Completes Public Offering Of 3.125% Senior Notes Due 2022 For US$675 Million 69
Medtronic Completes Public Offering Of 4.5% Senior Notes Due 2042 For US$400 Million 71
Medtronic Completes Public Offering Of Senior Notes Due 2021 For US$500 Million 73
Medtronic Completes Public Offering Of Senior Notes Due 2016 For US$500 Million 74
Spectranetics Acquires Stellarex from Covidien for USD30 Million 75
Capricor Therapeutics Acquires Intellectual Property Rights to Natriuretic Peptides from Medtronic 76
Covidien Plans to Divest Vascular Therapies Business 77
Medtronic Acquires Diabeter 78
Medtronic Acquires Covidien for USD49.9 Billion 79
Medtronic May Acquire Smith & Nephew 81
Medtronic Plc, Key Competitors 82
Medtronic Plc, Key Employees 83
Medtronic Plc, Other Locations 85
Medtronic Plc, Subsidiaries 85
List of Figures
Medtronic Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Medtronic Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Medtronic Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Medtronic Plc, Medical Devices Deals, 2011 to YTD 2017 12
